A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets

Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer

(2009) Jordi Camps et al.   GENES CHROMOSOMES & CANCER

RPS2: a novel therapeutic target in prostate cancer

(2009) Min Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

(2009) Jessica Kao et al.   PLoS One

Analyzing gene perturbation screens with nested effects models in R and bioconductor

(2008) H. Frohlich et al.   BIOINFORMATICS

Estimating large-scale signaling networks through nested effect models with intervention effects from microarray data

(2008) H. Frohlich et al.   BIOINFORMATICS

Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4α

(2008) Betty Schwartz et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers

(2008) J. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver

(2008) M J Gray et al.   ONCOGENE

Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics

(2008) A. S. Goldstein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis

(2008) Chi-Hwa Wu et al.   PLoS Genetics